The US Minimally Invasive Surgical Instruments Market was valued at $3002.1 Million in 2024 and projected to reach to $4775.9 Million by 2029, representing a compound annual growth rate of 9.7%. The US minimally invasive surgical instruments market is positioned for sustained growth through 2029, driven by technological advancements, increasing surgical volumes, and healthcare provider investments in modern operating room infrastructure.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The US minimally invasive surgical instruments market reached $3,002.1 million in 2024, demonstrating strong market maturity and adoption across healthcare facilities nationwide.
Expected to grow at a CAGR of 9.7% through 2029, reaching $4,775.9 million, outpacing the global average of 9.5% and reflecting US market leadership in surgical innovation.
The US benefits from advanced healthcare infrastructure, high reimbursement rates, and strong regulatory frameworks that accelerate adoption of minimally invasive technologies across hospitals and surgical centers.
Growing preference for MIS instruments driven by reduced patient trauma, shorter recovery times, lower infection rates, and decreased hospital costs, aligning with value-based care initiatives.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | ROBOTIC INSTRUMENTS (Product) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 9.5% from 2024 to 2029 |
| Largest Segment | NON-ROBOTIC SURGERY (Technology) |
| Market Size Base Year (Billions) | ~USD 31.7 (2024) |
| Revenue Forecast (Billions) | ~USD 49.9 (2029) |
| Segments Covered | Product, Type, Technology, Type Of Surgery, End User |
5 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY SURGERY CENTERS | 4745.3 | 5017.4 | 5465.7 | 5969.3 | 6535.9 | 7174.7 | 7888.8 | 8711.9 | 9.8 |
| HOSPITALS & SPECIALTY CLINICS | 7285.9 | 7739.8 | 8470.8 | 9294.7 | 10224.8 | 11276.7 | 12457.2 | 13821.5 | 10.3 |
| TOTAL | 12031.3 | 12757.2 | 13936.5 | 15263.9 | 16760.7 | 18451.4 | 20346 | 22533.3 | 10.1 |
The US minimally invasive surgical instruments market was valued at $3,002.1 million in 2024 and is projected to grow to $4,775.9 million by 2029.
The US market is expected to grow at a compound annual growth rate (CAGR) of 9.7% from 2024 to 2029.
Key drivers include increasing adoption of advanced surgical technologies, favorable FDA regulatory approvals, strong reimbursement policies, surgeon training initiatives, and the US healthcare system's emphasis on reducing patient recovery time and hospital costs.
The US market encompasses laparoscopic instruments, robotic-assisted surgical systems, endoscopic devices, imaging technologies, and specialized hand instruments used in minimally invasive procedures across multiple surgical specialties.
The US market includes both established medical device manufacturers with extensive product portfolios and emerging innovators developing next-generation technologies, competing across laparoscopic, robotic, and endoscopic segments.
The objective of the study is analyzing the key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies. To track companies’ developments such as product launch, approval, acquisition, agreement and expansion of the leading players, the competitive landscape of the minimally invasive surgical instruments market to analyzes market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments the market breakdown and data triangulation were used.
The four steps involved in estimating the market size are
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.
The following is a breakdown of the primary respondents:

Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2022, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
|
COMPANY NAME |
DESIGNATION |
|
Medtronic PLC (US) |
Marketing Manager |
|
Johnson & Johnson (US) |
Senior Product Manager |
|
Intuitive Surgical Inc. (US) |
Marketing Manager |
Both top-down and bottom-up approaches were used to estimate and validate the home healthcare market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

To know about the assumptions considered for the study, Request for Free Sample Report

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Minimally invasive surgery (MIS) is a surgical procedure done in a manner that causes little to no trauma or injury to a patient. MIS is executed through a cannula using lasers, endoscopes or laparoscopes. MIS involves less bleeding, smaller amounts of anesthesia, less pain, and minimal scarring than other procedures. The surgical instruments used to make minute incisions in the body and perform MIS procedures are minimally invasive.
MarketsandMarkets offers the following customizations for this market report
Full forecast, segment splits, and company analysis for all Minimally Invasive Surgical Instruments Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report